Cancer discovery news

Cancers develop partly through genetic abnormalities within cells of the body. Colorectal cancer is a major cause of death worldwide, but we don’t yet have a full understanding of the genetic changes that cause it to grow. New research – published today in Nature – delivers an unprecedented view of the genetic landscape of CRC and its responses to treatment.

Scientists have discovered that some cancer cells pretend to be ‘super fit’ to fool normal healthy cells into giving them their nutrients, allowing them to expand and spread around the body.

The Institute of Cancer Research, London, welcomes the news that a new targeted breast cancer drug, capivasertib, has been approved by the Medicines & Healthcare products Regulatory Agency (MHRA) for treating the most common type of advanced breast cancer.

Scientists have discovered a genetic aberration found in some prostate cancers that could allow more men to be successfully treated with targeted drug olaparib

Combining the principles of evolution with artificial intelligence (AI), scientists have proposed a new way to predict the chance of prostate cancer returning. In a recent study, they harnessed computational methods to capture specific tumour measurements relating to the tumour’s ability to change over time. They then showed that these measurements correlate with disease recurrence more than a decade after the initial diagnosis.

Researchers have mapped the exact variants in a gene that dramatically increase a person’s risk of developing several types of cancer. This could lead to improved early detection and targeted treatment across diverse populations.

Cancer’s resistance to chemotherapy could be reversed by targeting lactate – the product that builds up as cancer cells convert nutrients to energy – according to new research.

North Wales joins millions of participants worldwide for Terry Fox Run on 13 October. The Terry Fox Run UK raises funds for The Institute of Cancer Research, London. Wrexham, with the support of Ryan Reynolds, will become the first place in Wales to host a Terry Fox Run to honour Canadian hero Terry Fox.

Scientists have added to the list of inherited genetic mutations known to increase the risk of more aggressive prostate cancer.

The Institute of Cancer Research, London, congratulates the founders of the Chris Lucas Trust, our family charity partner, who are among those recognised in The King’s Birthday Honours List.

Kodiform Therapeutics, a new joint spin-out company from The Institute of Cancer Research, London, and the University of Oxford, has received a major seed funding investment from venture creation firm Oxford Science Enterprises.

Hundreds of thousands of people from across the country came together on Saturday to celebrate the life of the late Hairy Bakers TV star Dave Myers and raise thousands for our vital research.